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Occupational Awareness of Quality Assurance Program to
Lead Aprons Used by Cardiologists: Defect Analysis and Dose
Measurement
MARTIN LAW,1 TERRY CHENG,1 RAYMOND TANG,2 YUEN-CHI HO,1 STEVE LI,1 LAWRANCE YIP1
From 1Department of Radiology, Queen Mary Hospital; 2Department of Radiology, Grantham Hospital, Hong Kong
LAW ET AL.: Occupational Awareness of Quality Assurance Program to Lead Aprons Used by Cardiologists:
Defect Analysis and Dose Measurement. By visual inspection and fluoroscopic examination lead aprons, the procedures
of a quality assurance program to ensure occupational safety can be accurately performed in a cardiology unit with
in-house fluoroscopic apparatus by trained radiation personnel. (J HK Coll Cardiol 2014;22:35-37)
Cardiologist, lead apron, occupational dose, quality assurance

Introduction
Cardiologists are among the most intensive users
of radiation fluoroscopy in the medical profession.
While occupational protection in catheterization
laboratory is important, lead aprons are used for staff
protective apparel against ionizing radiation. 1 An
accurate and reliable quality assurance (QA) program
is recommended to maintain a high level of good
practice.2 In order to promote a practical QA program
for lead aprons in cardiology units in Hong Kong, results
are presented on defect analysis and dose measurement

Address for reprints: Dr. Martin Law
Department of Radiology, Room K-427, Queen Mary Hospital, Hong
Kong
Email: lawwm@ha.org.hk
Received June 26, 2014; accepted July 12, 2014

J HK Coll Cardiol, Vol 22

for a batch of lead aprons used by a group of
cardiologists. The program can be extended to perform
acceptance test to new lead aprons, from which lead
equivalent thickness deficiency is occasionally detected.
Therefore the important steps to start up a regular QA
program with associated resource are introduced. We
also share our experience to upcycle defective lead
aprons into clinical use to make the QA program
environmental friendly.

Methodology
Twenty-six lead aprons, estimated age between
3 years and 8 years old since their first use, were
assigned into different groups by their shapes (vest, skirt
and standard). We followed the annual QA program in
our institute, 3 based on which apron with defect
dimension ≥3 mm2 or the length of a fault line ≥2 cm
would be regarded as failure and then removed from
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occupational protection against ionization radiation.
Any visible defects, namely holes, cracks and tears, were
firstly evaluated and documented. The aprons were then
screened under X-ray fluoroscopy and sizes of defect
were measured.
A defective skirt apron, with crack length and
opening of about 12 cm wide, was chosen to measure
the radiation dose received at the defective site as if this
defective apron was used during interventional
procedure. A pelvis phantom, to simulate the lower body
of a cardiologist, was draped with this defective apron.
By placing three direct readout bleeper type pocket
dosimeters (Vertec, United Kingdom) at different
regions (defective, semi-defective and no-defect)
underneath the lead apron, radiation dose to the pelvis
phantom was measured to simulate a cardiologist
performing interventional procedure. As we would
compare between the dose underneath the defective sites
and that underneath properly shielded area of the apron,
the phantom draped with the defective apron was placed
on the X-ray tube side with routine fluoroscopy
irradiation.

Results
Five aprons (19%) were visually observed to have
different sizes of holes and/or tears associated with
fabric material of adhesive magic tape design.
One lead apron of skirt (4%) was observed to have
a crack with largest portion at about 12 cm width
observed under fluoroscopic screening. However there
was no visual defect on the fabric material for this skirt.
The radiation doses, as received by the
cardiologist performing interventional procedure with
the use of the defective apron, were measured with the
dosimeters underneath the defective, semi-defective
and no-defect regions. The measured doses were
18 µSv/min and 12 µSv/min underneath the defective
and semi-defective region respectively and underneath
the no-defective region of 1 µSv/min. It implied that
the regions with defective and semi-defective protection
would receive more than 10 times higher radiation
exposure than that of well protected region.
By visual inspection of this batch of aprons, it
was common to have exterior damages on the surface
36

of the fabric material. Torn fabrics were found at the
vicinity of the magic tapes. It was believed that the
textiles of the lead aprons could not withstand longterm tearing which might cause holes and tears. By
vigorously repeated pulling type force of the aprons,
holes and tears on the aprons were increasingly formed
in size. However defects within the lead lining enclosed
by the fabric material were difficult to detect visually
but could be examined with readily available X-ray
fluoroscopy method because of the high spatial
resolution for the fluoroscopic machine to detect defects
localization and size determination.

Discussion
In order to set up a long term tracking system for
the aprons, it is essential to have a systematic
management system and to train up operators for the
use of fluoroscopic machine. Information of the age
since its first use of aprons, date of previous QA test
and other updated status are usually not clearly labeled
and documented, all of which were experienced in the
batch of lead aprons as presented here. This situation is
more obvious when new aprons are regularly purchased
for replacement to be used along with those existing
ones, in addition to the situation of not easy to access to
privately owned lead aprons. A complete management
system with documentation for lead aprons is important.
There should be a person responsible for the
management of the lead aprons with reference to some
international criteria for rejecting defective aprons after
the QA testing.4
Trained operators in radiation machine play an
important role in the QA program. They should be
familiar with the fluoroscopy machine and have the
license to operate the radiation apparatus. If there are
defects on the lead aprons, operators should be
experienced to report the size and location. It is believed
that radiographers from radiology unit fulfill the above
requirements. They have much experience in using the
radiation machine including those in cardiology units.
The QA service of using fluoroscopic machine can be
arranged when the facility is not for patient service and
the radiographers still remain on duty in catheterization
laboratory.
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Despite regular check for existing lead aprons, it
is equally important to have the same program on new
aprons. From our experience, it cannot assume that new
lead aprons are perfect enough for radiation protection.
Not only tiny defects on lead aprons are found, but also
deficiency in the lead equivalence is occasionally
observed in new aprons. Wearing a defective or
insufficient lead equivalence lead apron violates the code
of practice in hospitals.5 Therefore, lead equivalent test
is essential before the occupational use of new aprons.
Physicist team in hospital is with experience and
knowledge in this area and in our institute, new apron
acceptance test is performed by physicist. Experience
can be shared to centres without the support of physicist.
The defective lead aprons should be disposed in
a proper way as the lead lining is composed of rubber
layers uniformly mixed with lead powder, both of which
are materials not friendly to our environmental disposal.
There are some programs in the radiology unit in our
institute studying the upcycle process for defective lead
aprons, in which the usable portions are cut into different
sizes of blankets to be clinically used as radiation
shielding during radiological imaging. An example of
this is to cover nuclear medicine patient pelvis region
with such blanket in order to reduce the radiation
exposure to staff during positioning the patient
undergoing imaging. Cardiology unit is suggested to
work with the radiology unit to upcycle the defective
aprons.

J HK Coll Cardiol, Vol 22

Conclusion
A defective lead apron may cause unnecessary
occupational exposure because of inappropriate
protection. Occupational dose would be accumulated
when defective aprons are regularly used. Therefore,
QA program for lead aprons should be established in
cardiology unit with available in-house equipment
and expertise to assure occupational safety. It is
recommended that the integrity of all new protective
aprons be verified upon receipt as well as at yearly
intervals. Upcycle of defective aprons is also suggested.
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Accordion Phenomenon: A Rare Cause of Acute Total Occlusion
During Percutaneous Coronary Intervention
DANNY HOI-FAN CHOW, CHUN-LEUNG LAU, PUI-SHAN CHU, HO-CHUEN YUEN, YING-KEUNG LO,
CHI-CHUNG CHOY, NGAI-YIN CHAN, PING-TIM TSUI, NGAI-SHING MOK
From Department of Medicine and Geriatrics, Princess Margaret Hospital, Hong Kong
CHOW ET AL.: Accordion Phenomenon: A Rare Cause of Acute Total Occlusion During Percutaneous Coronary
Intervention. Placement of stiff guidewires through tortuous coronary arteries allows smooth advancement of stents
during coronary intervention. However, the straightening of coronary vessels leads to a mechanical alteration and
induces vessel wall shortening. The transient effect of such coronary pseudo-stenosis is referred as "accordion
phenomenon". This case described the accordion phenomenon after placement of a stiff guidewire through a tortuous
right coronary artery leading to acute total occlusion with ST elevation during coronary intervention. (J HK Coll
Cardiol 2014;22:38-41)
Accordion phenomenon, pseudo-stenosis, stiff guidewire, ST-segment elevation

S T
T

Case Report
A 63-year-old gentleman who was an ex-smoker
had history of diabetes mellitus, hyperlipidemia, and
hypertension. He was admitted for inferior ST elevation
myocardial infarction (STEMI) treated with
tenecteplase (TNK). Peak Troponin I was 90.67 ug/L.
He initially refused coronary intervention and was
treated medically. He presented again with inferior
STEMI a year later and was complicated with heart
failure. He was treated with TNK within 3 hours. Peak

Address for reprints: Dr. Danny H.F. Chow
Department of Medicine and Geriatrics, Princess Margaret Hospital,
Hong Kong
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Troponin I was 87.52 ug/L. The gentleman finally
agreed for early invasive procedure in view of repeated
myocardial infarctions.
During diagnostic angiogram through the right
radial approach, there was difficulty in advancing a
5 French Tiger II catheter. Angiogram confirmed high
radial artery remnant. Coronary angiogram showed
normal left main artery, proximal left anterior
descending artery (LAD) 90% stenosis, middle LAD
90% stenosis, distal LAD 70% stenosis, and the left
circumflex artery was small in calibre. The right
coronary artery (RCA) ran a very tortuous course with
middle RCA 90% stenosis and posterior left ventricular
branch (PLV) 80% stenosis (Figure 1).
Percutaneous coronary intervention (PCI) to RCA
was performed. Because of the tortuosity of the RCA
and high radial remnant, an ASAHI 6.5 French
shealthless Amplatz 1 guiding catheter and a Finecross
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MG microcatheter (Terumo, Japan) were used for
supporting the 0.014-in. Runthrough guidewire.
(Terumo, Japan). The distal RCA was wired with
difficulty and was later exchanged to a 0.014-in. ASAHI
GRAND SLAM (Abbott Vascular, USA) through the
finecross catheter for better support.
Electrocardiogram suddenly showed ST elevation
over lead II and patient complained of severe chest pain.
Angiogram showed acute total occlusion of flow in
middle RCA (Figure 2). The Grand Slam guidewire was
withdrawn half way with the floppy part of the guidewire
in middle RCA and the flow was improved to TIMI III
with improvement of symptoms (Figure 3). A 3.0*15
mm stent (Energy®, Biotronik, Germany) was deployed
at middle RCA lesion at 14 atm after predilatation with
2.0*10 compliance balloon (Tazuna®, Terumo, Japan)
at 14 atm. The PLV branch was rewired with the
Runthrough guidewire with finecross support and later
exchanged with 0.014-in. Sion Blue guidewire (Asahi,
Japan). However, a 2.5*18 stent (Energy®, Biotronik,
Germany) failed to advance through the first bend of
RCA through the Sion blue guidewire. There was
frequent backing of the guidewire due to the vessel
tortuosity during exchange of guidewires through the
Finecross catheter. Therefore, a Crusade catheter

(A)

(Kaneka, Japan), a double-lumen multifunctional
probing microcatheter, was used to exchange for the
Grand Slam guidewire. Not only did the Crusade
catheter allow the exchange of guidewires, the catheter
also allowed both the Grand Slam guidewire and
Runthrough guidewire to act as buddy wires. The Grand
Slam guidewire was withdrawn partially prior the
delivery of the stent to the PLV branch to avoid the
accordion effect, so an accurate road map can be
recorded for the location and size of the PLV stent. The
2.5*18 stent (Energy®, Biotronik, Germany) was finally
advanced to PLV and was deployed at 14 atm. Post
dilatations with to middle RCA stent and PLV stent were
done with 3.5*10 non-compliant balloon (Hiryu ®,
Terumo, Japan) up to 14 atm and 2.5*8 non-compliant
balloon (Pentera Leo ®, Biotronik, Germany) up to
14 atm respectively.
PCI to middle LAD was done with ASAHI 6.5
French shealthless Judkins Left 3.5 guiding catheter.
Distal LAD was wired with Sion Blue guidewire.
A 3.0*15 (Multilink®, Medtronic, USA) was deployed
at 16 atm to middle LAD lesion through buddy wire
technique with Grand Slam guidewire. A 3.5*12 stent
(Multilink®, Medtronic, USA) was deployed at 14 atm
at the proximal LAD lesion.

(B)

Figure 1. Angiogram of right coronary artery (RCA) showed a tortuous RCA anatomy. (A) Right Anterior Oblique (RAO) view
of RCA; (B) Left Anterior Oblique (LAO) of RCA.
J HK Coll Cardiol, Vol 22
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(A)

(B)

Figure 2. Angiogram of right coronary artery (RCA) after wiring with GRAND SLAM guidewire showing acute
total occlusion of middle RCA. Underlying electrocardiogram showed ST elevation. (A) Right Anterior Oblique
view of RCA with GRAND SLAM guidewire; (B) Angiogram of Left Anterior Oblique view of RCA with GRAND
SLAM guidewire.

(A)

(B)

Figure 3. (A) Left Anterior Oblique and (B) Right Anterior Oblique view of right coronary artery after withdrawal of GRAND
SLAM wire showed recovery of TIMI III flow.

40
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Discussion

a stiff guidewire during the delivery of the PLV stent,
illustrating slight anatomical change can alter the
accordion outcome.
To differentiate the accordion phenomenon
from other differential diagnosis, it is recommended
to withdraw the guide wire while keeping the floppy
part of the wire in vessel. 4 Withdrawal of the
guidewire will allow coronary blood flow to improve.
However, one must document clearly the desired stent
placement location upon withdrawal of the guidewire
as the accordion effect will recur once the stiff
guidewire is advanced for the stent deployment.
Totally removing the guidewire is discouraged
because the operator may not be able to rewire the
lesion if the cause of the acute vessel closure is due
to dissection or distal embolism.

This case demonstrates the importance to
recognize the effect of "accordion" or "concertina"
phenomenon. The use of sheathless guiding catheter
allows its advancement a small, high radial remnant
artery without perforation. With the use of an extra
support guidewire, the angiographic geometry was
altered, resulting in straightening of the curvature of a
tortuous RCA (Figure 4). Previous case reports 1-3
demonstrated invagination of vessel wall during
angiogram. If the phenomenon is not recognized early,
unnecessary stent deployment may occur. Accordion
causing ST elevation with acute total occlusion is rare.
Differential diagnosis of acute vessel closure during PCI
include dissection, spasm, and embolization. Despite
the fact that accordion phenomenon is a well-recognized
effect of stiff guidewires, the use of stiff wires to gain
support through tortuous vessels to allow smooth
advancement of stents is sometimes inevitable. Delivery
of stent to PLV branch would be extremely difficult in
this case without a good guiding catheter support, strong
guidewire, and a well-prepared proximal passage. This
is supported in the case when the stent failed to advance
through the bend through non-stiff guidewires (Sion
Blue) during the PCI to PLV branch. Therefore, the
middle RCA lesion was stented prior the delivery of
the stent to the PLV branch. A special point of note is
that the accordion effect did not recur despite the use of

(A)
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(B)

Figure 4. (A) The anatomy and tortuosity of right coronary artery (RCA) is preserved with non-stiff Sion Blue guidewire.
(B) Use of GRAND SLAM stiff guidewire straightened tortuosity of the RCA. The arrow highlighted the straightened bend of
the original RCA anatomy.
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Endovascular Closure of a Subclavian Artery Pseudoaneurysm
VIKAS SINGH1 AND PRAKASH KUMAR2
From 1Department of Cardiology, Paras HMRI Hospital, Patna; 2Department of Cardiology, LPS Institute of
Cardiology, Kanpur, India
SINGH AND KUMAR: Endovascular Closure of a Subclavian Artery Pseudoaneurysm. Accurate diagnosis and
anatomical delineation of pseudoaneurysm is important for the precise management of the patient. A number of
techniques like ultrasonography, Doppler imaging, computed tomography angiography, magnetic resonance
angiography as well as conventional angiography are currently available. The image submitted shows the sequential
steps in the endovascular management of one such pseudoaneurysm. (J HK Coll Cardiol 2014;22:42-43)
Covered stent, endovascular closure, pseudoaneurysm, subclavian artery

CT

MR

Introduction
Pseudoaneurysms are encapsulated hematomas
that communicate with an artery because of an
incomplete seal by the media. Due to their noncompressibility, relative proximity to vital structures,
likelihood of distal thromboembolism and the
unpredictable risk of rupture, they pose unique
challenges in the management. Accurate delineation of
the aneurysm is very important for efficient management
whether planned percutaneously or by open technique.
Endovascular closure has its own advantages because
shorter operative time, less bleeding and a shorter
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hospital stay. Open technique is more likely to give
problems like injury to nerve trunks in vicinity and
difficulty handling branches particularly in presence of
active bleed/hematoma.

Case
This 40-year-old male had a history of gunshot
injury over left shoulder region a month prior to
presentation; and was being managed conservatively
with intercostal tube drainage for left hemothorax
when he started noticing weakness of left upper limb.
L e f t b r a c h i a l p l ex u s i n j u r y wa s s u s p e c t e d .
Ultrasonography of the neck was done for brachial
plexus evaluation which showed that infraclavicular
part of brachial plexus trunk was severed. In addition,
there was a mass in distal part of subclavian artery.
Computed tomography (CT)-angiography was done
which showed it to be a pseudoaneurysm in distal part
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of left subclavian artery. Diagnostic peripheral
angiography of left upper limb was done which showed
a wide neck aneurysm, in the distal part of left
subclavian artery directed posteriorly and superiorly
(Figure 1a).
Endovascular procedure was performed via
access through the right femoral artery. Using 8F
multipurpose guiding catheter, pseudoaneurysm
was crossed with a floppy wire (Figure 1b) and then
0.035" exchange wire was crossed (Figure 1c).

Endovascular exclusion of the pseudoaneurysm was
achieved with the deployment of a 6x22 mm balloon
expandable peripheral stent-graft (Advanta, ATRIUM
MEDICAL CORPORATION; Hudson, NH, USA)
within the lumen of left subclavian artery (Figures
1d & 1e). The process was done under the cover of
unfractionated heparin 5000 U, the ACT was
m a i n t a i n e d a b ove 2 2 0 s e c o n d s . C o m p l e t i o n
angiography showed complete closure and exclusion
of the pseudoaneurysm (Figure 1f).

Figure 1. (a) Diagnostic peripheral angiography of left upper limb showing a wide neck aneurysm, in the distal
part of left subclavian artery directed posteriorly and superiorly. (b) Using 8F multipurpose guiding catheter,
pseudoaneurysm was crossed with a floppy wire. (c) The floppy wire has been exchanged with a 0.035" exchange.
A 6 x 22 mm balloon expandable peripheral stent-graft (Adventa, Atrium Medical Corporation) placed within the
lumen of left subclavian artery covering both the edges of the neck. (d) The balloon expandable stent deployed in
the artery. (e) The deployed stent can be visualised under fluoroscopy. (f) Post-deployment peripheral angiography
showing exclusion of the pseudoaneurysm, and no extravasation of the dye.
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Abstracts for Invited Lectures:
IL2.
OVERCOMING BARRIERS TO THE USE OF HUMAN
PLURIPOTENT STEM CELLS DERIVED
CARDIOMYOCYTES FOR EXPERIMENTAL AND
THERAPEUTIC APPLICATIONS
K Boheler
The University of Hong Kong, Hong Kong

characterised, these subpopulations, corresponding to different stages of in
vitro differentiation should permit more robust disease modelling and
pharmacotoxicology studies; and in the long-term, may help identify suitable
cells for therapeutic applications. In summary, cell surface-centric research
strategies are useful for the identification of markers for drug repurposing,
positive or negative selection, as well as functional characterizations of better
defined populations of hPSCs and hPSC-derived progeny.

Knowledge of cell-surface proteins for isolating well-defined populations of
human pluripotent stem cells (hPSCs) and their progeny will significantly
enhance the characterization and translational potential of these cells. Using
a chemoproteomic approach, we have developed a cell surface proteome
repository containing 500 N-linked glycoproteins on human embryonic
(hESCs) and induced PSCs (hiPSCs) and >600 glycoproteins from hPSCcardiomyocytes (CMs). When compared with human fibroblasts and 50 other
cell types, >100 surface proteins of interest for hPSCs and human PSC-CMs
were revealed. The >30 positive and negative markers for the human PSCs
verified by orthogonal approaches provide experimental justification for the
rational selection of pluripotency and lineage markers, epitopes for cell
isolation, and reagents for the characterization of putative hiPSC lines.
Quantitative differences between the chemoproteomic-defined surfaceome
and the transcriptome-predicted surfaceome directly led to the discovery of
two novel metabolic inhibitors specifically toxic to hPSCs and efficient for
selective elimination of hPSCs from mixed cultures, without significantly
toxicity on more differentiated cell types. From the human PSC-derived CMs,
we have been able to identify several surface proteins that appear apt for the
selection of subpopulations of cardiomyocytes from mixed cultures. Once

IL3.
NON-ENDING SEARCH FOR THE BEST
PHARMACOLOGICAL VASODILATOR FOR CORONARY
ARTERY BYPASS GRAFTS
GW He
TEDA International Cardiovascular Hospital, Tianjin & The Affiliated Hospital
of Hangzhou Normal University & Zhejiang University, Hangzhou, China;
and Department of Surgery, Oregon Health and Science University, Portland,
Oregon, U.S.A.
In comparison with standard saphenous vein grafts, use of the internal
mammary artery (IMA) as a coronary artery bypass graft has achieved
superior long-term results. This is obviously related to the differences in
biological characteristics between the venous and arterial grafts. However,
even arterial grafts are not uniform in their biological characteristics. The
variation in the perioperative behavior of the grafts and in their long-term
patency may be related to different characteristics. These factors should be
taken into account in the use of arterial grafts, some of which are subjected
to more active pharmacological intervention during and after the operation
to obtain satisfactory results. To better understand the biological behavior
of the grafts, their common features and their differences, a clinical
classification may be useful for a practicing surgeon. Based on experimental
studies of their vasoreactivity combined with anatomical, physiological, and
embryological considerations, we have proposed a functional classification
for arterial grafts that may be useful clinically. Our classification suggests
that there are three types of arterial grafts: Type I- somatic arteries; Type IIsplanchnic arteries; and Type III- limb arteries. The Type I arteries have
better endothelial function and release more nitric oxide and other relaxing
factors; the Type II arteries, such as the gastro-epiploic artery, and the Type
III arteries, such as the radial artery, have higher pharmacological reactivity
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to vasoconstrictors. This classification explains why the IMA has the best
long-term patency. Because Type II and III arteries are prone to spasms due
to higher contractility, they require more active pharmacological
interventions. Furthermore, the harvesting technique of the conduits,
including saphenous vein and IMA, are described and discussed in this
article. Prevention of spasms using two cocktails of medications
(verapamil+nitroglycerin and nicardipine+ nitroglycerin) during harvesting
of the conduits is described. Those solutions have been demonstrated to be
clinically effective. With development of new vasodilator substances, such
as third-generation calcium channel blockers, more effective and safer antispasm drugs for CABG may become feasible in the future.

October 2014

47

ICSM, THE EIGHTEENTH ANNUAL SCIENTIFIC MEETING
ABSTRACTS
Abstracts for Oral Presentation:
OP1.
KNOCKDOWN OF REPRESSOR ACTIVATOR PROTEIN 1
FACILITATED FOAM CELL FORMATION BY
AUGMENTING CHOLESTEROL UPTAKE
HK Wong, 1 Y Cai, 1 EHC Tang 1,2
Department of Pharmacology and Pharmacy; 2Department of Physiology,
The University of Hong Kong, Hong Kong
1

Objectives: Repressor activator protein 1 (Rap1) is a telomere-associated
protein with telomeric-regulating functions, but it also displays non-telomeric
functions and regulates metabolism. The expression of Rap1 is enhanced in
atherosclerotic plaques. Presence of foam cells is an indicator of plaque buildup. This study aims to investigate if Rap1 knockdown has an effect on foam
cell formation and cholesterol transport.
Methods: Knockdown of Rap1 was established in macrophage cells derived
from the human monocytic leukemia cell line (THP-1) using small interfering
ribonucleic acid (RNA). Knockdown and wild-type cells were transformed
into foam cells by incubating with 50 µg/mL acetylated low-density
lipoprotein for 72 hours. Then the cells were stained with oil red O to assess
the efficiency of foam cell formation, or subjected to RNA extraction to
study the expression of key genes involved in cholesterol transport by
quantitative polymerase chain reaction.

Results: Rap1 knockdown cells accumulated 40.9%±14.7% more
intracellular lipids (P<0.05). The mRNA expression of peroxisome
proliferator-activated receptors alpha (PPARα) increased by 3.04-fold
(P<0.05), while peroxisome proliferator-activated receptor-gamma
coactivator (PGC1α) was significantly reduced by 89%±2.2% (P<0.03) in
Rap1 knockdown cells as compared with wild-type cells. The mRNA
expression of scavenger receptor A (SR-A) in Rap1 knockdown increased
by 4.79-fold (P<0.02), while there is no significant change in the expression
of another cholesterol uptake receptor − cluster of differentiation 36 (CD36),
and other efflux-associated genes − including ATP binding cassettes A1 and
G1 (ABCA1 and ABCG1) and scavenger receptor B1 (SR-B1) was observed.
Conclusions: Rap1 knockdown enhanced foam cell formation and
significantly affected the mRNA expression of master transcriptional
regulators − PPARα and PGC1α. Effective foam cell formation is accounted
by increased SR-A expression and hence enhanced cholesterol uptake, which
warrants further studies to confirm such postulation.

OP2.
AMELIORATION OF CIGARETTE SMOKE-INDUCED
CARDIAC DYSFUNCTION AND INFLAMMATION BY
MESENCHYMAL STEM CELLS
YM Liang,1 X Li,1 YL Zhang,1 Z Zhen,1 SC Yeung,1 MSM Ip,1,4 HF Tse,1
QZ Lian, 1,2,4 JCW Mak 1,3,4
Departments of 1Medicine; 2Ophthalmology; 3Pharmacology & Pharmacy;
4
Research Centre of Heart, Brain, Hormone and Healthy Aging, The University
of Hong Kong, Hong Kong
Objectives: Cigarette smoke (CS) is recognized as a major cause of
cardiovascular disease (CVD). Inflammatory responses play important roles
in the pathophysiological processes of CS-induced cardiac damage.
Mesenchymal stem cells (MSCs) are regarded as a promising candidate for
cell-based therapy in CVD. We aimed to compare the effects of bone marrowderived MSCs (BM-MSCs) and induced pluripotent stem cell-derived MSC
(iPSC-MSCs) on cardiac function and inflammation in CS-exposed rat model.
Methods: Male Sprague-Dawley rats were exposed to 4% CS for one hour
daily for 56 days. On day 29 and day 43, human iPSC-MSCs or adult bone
marrow-MSCs (BM-MSCs) were administered intravenously to CS-exposed
rats. Echocardiography was conducted 24h after the last exposure and animals
were sacrificed. Heart tissues were collected for paraffin sectioning and
protein extraction to determine levels of pro-/anti-inflammatory cytokines.
Results: iPSC-MSC-treated group had a greater effect in the improvement
of CS-induced cardiac dysfunction, myocardial hypertrophy and interstitial
fibrosis than BM-MSC-treated group. The CS-induced elevation of cardiac
pro-inflammatory cytokines, tumor necrosis factor-alpha (TNF-α), cytokine-
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induced neutrophil chemoattractant-1 (CINC-1, resemble to human IL-8)
and monocyte chemoattractant protein-1 (MCP-1) was attenuated by either
iPSC-MSCs or BM-MSCs administration. However, CS-induced reduction
of cardiac anti-inflammatory cytokines, interleukin-10 (IL-10) and
adiponectin, was restored only by iPSC-MSCs administration. Both
treatments reversed CS-induced reduction of cytoplasmic IκBα expression
and nuclear translocation of nuclear factor-κB (NF-κB) p65 subunit.
Conclusions: Our findings demonstrate a higher capacity of iPSC-MSCs
than BM-MSCs to ameliorate CS-induced cardiac dysfunction and cardiac
remodeling via NF-kB signaling pathway by inhibiting pro-inflammatory
cytokines and restoring anti-inflammatory cytokines in CS-exposed rat model.
iPSC-MSCs may thus hold promise for the development of cell-based therapy
in cardiac protection.
This work is supported by the Hong Kong Research Grant Council General
Research Fund (RGC GRF) 2010-2011 [HKU 774410M] and National Natural
Science Foundation of China [No 81370140].
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OP3.
ENDOTHELIUM-, SOLUBLE GUANYLYL CYCLASEDEPENDENT CONTRACTIONS IN ISOLATED ARTERIES
CM Detremmerie,1 SWS Leung,1 A Xu,1 Y Gao,2 PM Vanhoutte1
1
Department of Pharmacology, Li Ka Shing Faculty of Medicine, The
University of Hong Kong, Hong Kong; 2Department of Physiology and
Pathophysiology, Peking University, Health Science Center, Beijing, China
Objectives: This study focuses on the effects of thymoquinone on isolated
arteries, by determining the mechanisms underlying the endothelium- and
soluble guanylyl cyclase (sGC)-dependent augmentation of contraction that
this natural compound causes, comparable to the augmentation described
under hypoxic conditions.
Methods: Experiments were designed to study the effect of thymoquinone
ex vivo in isolated porcine coronary and rat arteries. Rings, with or without
endothelium, were suspended in conventional organ chambers for isometric
tension recording. Certain rings were incubated with inhibitors of nitric oxide
(NO) synthase (L-NG-nitroarginine methyl ester, LNAME), sGC (1H-[1,2,
4]oxadiazolo[4,3-a]quinoxalin-1-one, ODQ), rhoassociated protein kinases
(Y-27632) or L-type voltage-gated calcium channels (nifedipine). Some of
the control experiments were done under depleted calcium conditions. The
rings were contracted with phenylephrine (rat arteries) or prostaglandin F2α
(porcine coronaries) and exposed to increasing concentrations of
thymoquinone. Selected rings were used to measure cyclic nucleotide levels
by HPLC-MS/MS.

Results: Thymoquinone caused a sustained further increase in tension in
rings with endothelium. This augmentation was prevented b y
endotheliumremoval, L-NAME and ODQ. Incubation with the NO-donor
DETA NONOate in L-NAME-treated rings restored and even increased the
contractile response to thymoquinone. Treatment with 8-bromo guanosine
3':5' cyclic monophosphate (cyclic GMP) or pyrophospate did not restore
the augmentation by thymoquinone. HPLC-MS/MS measurements revealed
that the compound increased the production of inosine 3':5' cyclic
monophosphate (cyclic IMP). Y-27632, nifedipine and calcium depletion
inhibited the thymoquinone-induced contraction in porcine coronary arteries,
but not in rat aortae.
Conclusions: The endothelium-dependent augmentation caused by
thymoquinone requires endothelium-derived NO and activation of sGC, as
described under hypoxic conditions. In addition, both thymoquinone- and
hypoxiainduced augmentations require production of cyclic IMP but not the
presence of either pyrophosphate or cyclic GMP. The data suggest that cyclic
IMP causes vasoconstriction through calcium sensitization, although the
underlying mechanism seems to differ in rat and porcine arteries. Taken into
conjunction, thymoquinone can serve as a pharmacological tool to study/
mimic the endothelium-dependent vasoconstrictor effects of intermittent
hypoxia, as seen in the clinical setting of sleep apnea patients.

OP4.
ENDOTHELIAL DYSFUNCTION CAUSED BY INCREASED
PRESSURE IN ADULT MOUSE CAROTID ARTERIES IS
MEDIATED BY LOCAL ANGIOTENSIN SIGNALING
YZ Zhao,1,2 S Flavahan,1 SWS Leung,2 A Xu,2 PM Vanhoutte,2 NA Flavahan1
Department of Anesthesiology and Critical Care Medicine, Johns Hopkins
University, Baltimore, MD, USA; 2Department of Pharmacology and Pharmacy
and State Key Laboratory of Pharmaceutical Biotechnology, The University
of Hong Kong, Hong Kong

1

Objectives: Experiments were performed to determine whether acute
elevation of pressure in isolated arteries would impair endothelium-dependent
dilatation by increasing angiotensin II signaling or by directly activating AT1
receptors.
Methods: Dilatation of adult mouse isolated carotid arteries was analyzed
in a myograph at 80 mmHg. Western blotting was used to detect the expression
of angiotensinogen in arteries.
Results: Acetylcholine caused dilatation that was significantly reduced by
endothelial denudation or by inhibition of NO synthase (L-NAME, 10-4 M).
Transient exposure of arteries to increased pressure (150 mmHg, 3 hours)
inhibited responses to acetylcholine, but did not affect dilatation to the NO
donor DEA-NONOate. Inhibition of angiotensin II signaling, by blocking
AT1 receptors with the competitive antagonist losartan (3×10-6 M) or the
inverse agonist valsartan (10-6 M) or by inhibiting angiotensin converting
enzyme with perindoprilat (10 -6 M) or captopril (10 -5 M) prevented the
impairment of endothelium-dependent dilatation by elevated pressure, but
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did not affect dilatation to the agonist in arteries maintained at 80 mmHg.
Elevated pressure caused a marked expression of angiotensinogen.
Exogenous angiotensin II (3×10 -7 M, 3 hours) inhibited responses to
acetylcholine in arteries transiently exposed to increased pressure, but had
no effect in arteries maintained at 80 mmHg.
Conclusions and implications: Exposure of adult arteries to elevated pressure
rapidly impairs endothelium-dependent dilatation by causing expression of
angiotensinogen and enabling angiotensin II-dependent activation of AT1
receptors. Elevated pressure also amplified the response to exogenous
angiotensin II. These processes likely contribute to the pathogenesis of
hypertension-induced vascular dysfunction and organ injury.
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OP5.
REPRESSOR ACTIVATOR PROTEIN 1 INDUCES PROI N F L A M M ATO RY C Y TO K I N E S P RO D U C T I O N I N
MACROPHAGES THROUGH NFKB SIGNALING
Y Cai, PM Vanhoutte, EHC Tang
Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of
Medicine, The University of Hong Kong, Hong Kong
Objectives: Repressor activator protein 1 (Rap1), an established telomereassociated protein migrates to the cytoplasm and activates nuclear factor
kappa B (NFκB) in human carcinoma cell lines. The present study tested
the hypothesis that Rap1 induces production of pro-inflammatory cytokines
via NFκB signaling in macrophages, a cell type involved in the development
and progression of atherosclerotic lesions.
Methods: Small interfering RNA technology was used to knockdown Rap1
in THP-1 monocytic cells. The expression of lipopolysaccharide-(LPS)
induced NFkB dependent genes and proteins in wild type (Rap1WT) and Rap1
knockdown (Rap1KD) cells were measured using real-time PCR and enzymelinked immunosorbent assays. Co-immunoprecipitation assay was used to
identify the protein-protein interaction. Western blotting was applied to
determine the expression of Rap1 and proteins involved NFê B signaling
pathway (including IKKα, IKKβ, IκBα, p65 and their phosphorylation forms)
in Rap1WT and Rap1KD THP-1 cells. The expression of Rap1 and macrophages
in human atheromatous lesions was detected by immunohistochemistry.

Results: Rap1 was present in the cytoplasm of differentiated THP-1 cells
and associated with IKK. Knockdown of Rap1 suppressed LPS-mediated
activation of NFκB, and phosphorylation of IκBα and p65 in THP-1. The
reduction of NFκB activity was paralleled by a decreased production NFκBdependent pro-inflammatory cytokines [including interleukin (IL)-8, IL-1α,
IL-6 and monocyte chemotactic protein-1], and an increased expression of
IL-10, an NFκB-dependent anti-inflammatory cytokine. Immunostaining
revealed that Rap1 localized to macrophage-rich areas in human
atherosclerotic plaques and that the presence of Rap1 was positively correlated
to the advancement of the disease process.
Conclusions: In macrophages, Rap1 promotes cytokine production via NFκB
activation favoring a pro-inflammatory environment which may aggravate
the development and progression of atherosclerosis.

OP6.
ROLE OF IP RECEPTORS IN RENAL BASAL ARTERIAL
TONE AND ENDOTHELIUM-DEPENDENT CONTRACTIONS
O Baretella, A Xu, PM Vanhoutte
State Key Laboratory for Pharmaceutical Biotechnology, The University of
Hong Kong, Hong Kong
Objectives: Endothelium-dependent contractions are augmented in human
hypertension and in isolated preparations – including renal arteries – from
hypertensive animals. Renal vasomotor tone is essential in the regulation of
arterial blood pressure and renal arteries are highly sensitive to vasoconstrictor
prostanoids including prostacyclin, identified as endothelium-derived
contracting factor (EDCF) activating thromboxane prostanoid (TP) receptors.
However, the mechanisms underlying increased EDCF responses in
hypertension are not completely resolved.
Methods: Isometric tension was measured, in wire myographs at an optimal
resting tension, in renal arterial rings from spontaneously hypertensive (SHR)
and age (37-52 weeks)-matched Wistar Kyoto (WKY) rats. Responses were
compared under control conditions and after incubation with indomethacin
(cyclooxygenase inhibitor), ketanserin (5-HT 2 receptor antagonist),
CAY10441 (prostaglandin I 2 [IP] receptor antagonist), and S18886 (TP
receptor antagonist). All experiments were performed in the presence of
L-NAME to exclude effects of endothelium-derived NO.
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Results: Exposure to high potassium (High K+) depolarizing solution evoked
significantly larger contractions in SHR (16.7±0.7 mN) compared to WKY
(13.5±0.6 mN) preparations (36 rings each, P<0.01). CAY10441 (1 µmol/L)
contracted renal arterial rings from both strains. This contraction was also
significantly larger in SHR than in WKY renal arteries in absolute values,
but similar between the two groups when expressed relatively to High K+
reference contractions (92±5% vs 80±8%, n=6). The phenomenon was
curtailed by indomethacin, ketanserin, but not S18886. After washout and
re-incubation, EDCF-mediated responses to acetylcholine were similar
between SHR and WKY preparations in the presence of CAY10441
(Emax 72.6±5.3% and 67.4±3.8% High K+, n=8), but significantly larger than
under control conditions (n=4-8, P<0.05). S18886 prevented EDCFmediated responses in the absence but not in the presence of CAY10441.
Contractions to prostacyclin [in the presence of indomethacin] were
facilitated by CAY10441 in rings from both strains and no longer prevented
by S18886, although the TP receptor antagonist abolished contractions to
U46619.
Conclusions: These data suggest that: a) functional IP receptors are essential
for renal basal arterial vasomotor tone; b) these receptors are also critical in
the response to the endothelium-derived contracting factor prostacyclin; and
c) TP blockade loses efficacy during concomitant IP receptor antagonism.
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CP1.
DIFFERENTIAL MECHANISMS FOR INSULIN-INDUCED
RELAXATIONS IN MOUSE POSTERIOR TIBIAL ARTERIES
AND MAIN MESENTERIC ARTERIES
D Qu, J Liu, CW Lau, Y Huang
School of Biomedical Sciences, The Chinese University of Hong Kong, Hong
Kong
The characteristics of endothelium-dependent relaxations in response to
insulin and acetylcholine (ACh) in the mouse posterior tibial artery (PTA)
were studied on wire myograph, and compared to those in the mouse main
mesenteric artery (MMA). Insulin-induced relaxation in PTA was reversed
by PI3K and Akt inhibitors, LY294002 and triciribine, but not by nitric oxide
synthase inhibitor, NG-nitro-L-arginine methyl ester (L-NAME) or guanylate
cyclase inhibitor, ODQ. The relaxation in PTA was also inhibited by apamin
(small-conductance Ca2+-activated K+ channel blocker) plus charybdotoxin
(intermediate-conductance Ca2+-activated K+ channel blocker), elevated KCl
or ouabaine (Na+-K+ ATPase inhibitor) plus BaCl2 [inwardly rectifying K+
(KIR) channel inhibitor]; whereas L-NAME but not triciribine inhibited AChinduced relaxation in PTA. On the other hand, nitric oxide and endotheliumderived hyperpolarizing factor albeit to a less extent mediated both insulinand ACh-induced relaxations in MMA. The present study is for the first time
dissecting out the components of endothelium-dependent relaxation in mouse
PTA and suggesting differential responses to different agonists in distinctive
blood vessels.

CP2.
BLACK TEA AMELIORATES ENDOTHELIAL FUNCTION BY
INHIBITING ENDOPLASMIC RETICULUM STRESS IN
HYPERTENSIVE RATS
WS Cheang,1 CY Ngai,1 Z Chen,2 FP Leung,3 Y Huang1
1
School of Biomedical Sciences, The Chinese University of Hong Kong;
2
School of Life Sciences, The Chinese University of Hong Kong; 3Clinical
Division, School of Chinese Medicine, Hong Kong Baptist University, Hong
Kong

of Ang II-infused rats was normalized by black tea consumption. Impaired
endothelium-dependent relaxations in renal arteries, carotid arteries and
aortae, and flow-mediated dilatations in second-order mesenteric resistance
arteries were significantly improved in Ang II-infused rat treated with black
tea. Elevations of ER stress markers and ROS level in aortae from Ang IIinfused rats were prevented by black tea treatment. The present study reveals
the novel cardiovascular benefits of black tea in ameliorating vascular
dysfunctions, and provides insights into developing black tea into beneficial
dietary supplements in hypertensive patients (supported by GRF).

Hypertensive patients have elevated levels of homocysteine, known as
hyperhomocysteinemia. Homocysteine (Hcy) can induce endoplasmic
reticulum (ER) stress in endothelial cells. This study aims to investigate
whether black tea protects against hypertension-associated endothelial
dysfunction through alleviation of ER stress. Rat aortae and primary cultured
rat aortic endothelial cells were treated with Hcy, black tea extract (a mixture
of theaflavins), and theaflavin-3,3'-digallate (TF3). Male Sprague Dawley
rats were infused with angiotensin II (Ang II) to induce hypertension, and
orally administrated with black tea extract at 15 mg . kg-1 . day-1 for 2 weeks.
Blood pressure was measured. Vasoreactivities of different arteries were
examined on organ bath, wire myograph and pressure myograph. ER stress
markers and reactive oxygen species (ROS) production were assessed by
Western blotting and dihydroethidium fluorescence staining respectively. Hcy
impaired endothelium-dependent relaxations of rat aortae in a concentrationdependent manner and led to ER stress in endothelial cells, which were
ameliorated by co-incubation of black tea extract and TF3. The blood pressure
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CP3.
ROLE OF ER STRESS IN VASCULAR BKCa DYSFUNCTION
CAUSED BY HOMOCYSTEINE
WT Sun, XC Wang, CM Yu, Q Yang
Division of Cardiology, Department of Medicine and Therapeutics, Institute
of Vascular Medicine, Li Ka Shing Institute of Health Sciences, Institute of
Innovative Medicine, Faculty of Medicine, Chinese University of Hong
Kong; The Chinese University of Hong Kong Shenzhen Research Institute,
Hong Kong
Objectives: Large conductance Ca2+-activated K+ channels (BKCa) channels
play an essential role in the regulation of vascular tone. Although previous
studies suggested that inhibition of BKCa channels may contribute to vascular
dysfunction caused by homocysteine, by what mechanisms homocysteine
impairs BKCa channel function remains poorly understood. In this study, we
investigated the role of endoplasmic reticulum (ER) stress in homocysteineinduced BK Ca dysfunction in coronary arteries with a further attempt to
understand the signaling involved.
Methods: Isometric force studies were performed in endothelium-denuded
porcine small coronary arteries (<500 µm in diameter) in a myograph. Primary
cultured porcine coronary arterial smooth muscle cells (PCASMCs) were
used for western-blot analysis and whole-cell patch-clamp recording of BKCa
current.
Results: Exposure to homocysteine for 24 h significantly increased the protein
levels of ER stress molecules including GRP78, p-PERK and p-eIF2á. The
vasorelaxant response to the BKCa opener NS1619 was significantly attenuated
in arteries pre-incubated with homocysteine (62.2±3.0% vs. 85.4±2.9%,
p<0.01). Co-incubation of the arteries with homocysteine and the ER stress
inhibitor, either TUDCA or 4-PBA restored the relaxation (76.6±3.5% and

85.4±1.7%, respectively). Preservation of NS1619-induced relaxation was
also achieved by co-incubation with GSK2606414, a selective inhibitor of
PERK (77.0±2.8%). The protein level of β1 but not α subunit of BKCa was
lowered in PCASMCs after exposure to homocysteine, which was elevated
by the co-incubation with TUDCA, 4-PBA, or GSK2606414. The upregulation
of BKCa β1 protein expression was accompanied by the downregulation of
p-PERK and p-eIF2á. Inhibition of PERK enhanced the iberiotoxin-sensitive
BK Ca current (55.5±4.3 pA/pF) that was suppressed by homocysteine
(42.8±5.5 vs.70.1±8.7 pA/pF in control) in PCASMCs.
Conclusions: ER stress mediates homocysteine-induced smooth muscle BKCa
dysfunction in coronary arteries. Downregulation of BKCa β1 subunit by PERK
activation plays a key role in the loss of channel function.
Supported by RGC/GRF CUHK4774/12M; NSFC 81200123; and CUHK
Direct Grant 4054015, 4054104.

CP4.
ROLE OF TRPC3 IN ENDOTHELIAL KCa ACTIVITY:
EFFECT OF HYPOXIA-REOXYGENATION
XC Wang, WT Sun, CM Yu, Q Yang
Division of Cardiology, Department of Medicine and Therapeutics, Institute
of Vascular Medicine, Li Ka Shing Institute of Health Sciences, Institute of
Innovative Medicine, Faculty of Medicine, The Chinese University of Hong
Kong; The Chinese University of Hong Kong Shenzhen Research Institute,
Hong Kong
Objectives: We previously demonstrated the role of TRPC3 channels in
EDHF-mediated relaxation and the susceptibility of TRPC3 and EDHF to
hypoxia-reoxygenation (H-R) in coronary arteries. In this study, we further
investigated the significance of TRPC3 in endothelial IKCa and SKCa channel
activity under both normoxic and H-R conditions with exploration of the
association between TRPC3 and KCa in endothelial cells.
Methods: Primary cultured porcine coronary arterial endothelial cells
(PCAECs) were used. Whole cell K+ currents in response to bradykinin were
recorded by patch-clamping with further differentiation of IKCa and SKCa
components. Coimmunoprecipitation experiments using antibodies against
TRPC3 and IKCa, or TRPC3 and SKCa were conducted.
Results: Pretreatment of PCAECs with the specific TRPC3 inhibitor Pyr3
significantly inhibited the IKCa (6.71±0.85 vs. 16.89±0.93 pA/pF, p<0.01)
and SKCa (5.51±1.17 vs. 10.63±1.69 pA/pF, p<0.05) currents in response to
bradykinin. In PCAECs exposed to H-R (60-30 min), bradykinin-induced
IKCa (10.24±1.96 pA/pF) and SKCa (4.62±0.43 pA/pF) currents were markedly
suppressed (p<0.05) and Pyr3 exhibited less inhibition on both components
when compared with the cells without H-R exposure. The IK Ca and SKCa
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currents inhibited by Pyr3 were 10.18±0.73 and 5.12±1.22 pA/pF
respectively in normoxic PCAECs and 5.15±1.21 pA/pF and 3.14±0.49 in
cells underwent H-R (p<0.05). Coimmunoprecipitation experiments showed
no physical interactions between either TRPC3 and IKCa or TRPC3 and SKCa.
Conclusions: TRPC3 is involved in the activation of IKCa and SKCa channels
in coronary arterial endothelial cells. The functional association between
endothelial TRPC3 and KCa does not involve physical interaction. Inhibition
of TRPC3 contributes to H-R-induced suppression of channel activity of IKCa
and SKCa, which serves as a mechanism underlying endothelial dysfunction
under H-R condition.
Supported by RGC/GRF CUHK4774/12M; NSFC 81200123; and CUHK
Direct Grant 4054015, 4054104.
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CP5.
EFFECTS OF WY14643 AND FENOFIBRATE ON
ACETYLCHOLINE-INDUCED CONTRACTIONS IN AORTIC
RINGS FROM SPONTANEOUSLY HYPERTENSIVE RATS
H Chen, SWS Leung, RYK Man
Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of
Medicine, The University of Hong Kong, Hong Kong

endothelium. Both WY and FF partially inhibited the contractions in rings
with endothelium, but not in rings without endothelium, indicating that WY
and FF act on the endothelium to produce their inhibitory effects.
Conclusion: Both WY and FF reduce contractions evoked by acetylcholine
in aortic rings of SHR, which may result from their effects on decreasing the
production of reactive oxygen species.

Introduction and objective: Oxidative stress is implicated in the release of
endothelium-derived contracting factors, the release of which is associated
with endothelial dysfunction. Peroxisome proliferator-activated receptor
(PPAR) –alpha agonists, Wy14643 (WY) and fenofibrate (FF) have been
found improving endothelial function in cardiovascular diseases. The present
study was designed to examine whether or not WY and FF inhibit
endothelium-dependent contractions through reduction of free radicals in
aortae of spontaneously hypertensive rats (SHR).
Method: Male SHRs of 40-44 weeks old were used. Thoracic aortic rings
with and without endothelium were suspended in organ chambers for isometric
tension recording.
Results: Acetylcholine caused contractions in aortic rings with endothelium
in the presence of Nω-nitro-L-arginine methyl ester (an inhibitor of nitric
oxide synthase). Tiron (a scavenger of intracellular superoxide anion) plus
DETCA (an inhibitor of superoxide dismutase) significantly reduced the
responses, suggesting that oxygen-derived free radicals are involved in the
contractions. Both WY and FF significantly decreased the acetylcholineinduced contractions, suggesting that they may inhibit the production of
hydrogen peroxide or its downstream signaling mediators. Exogenous
hydrogen peroxide evoked contractions in aortic rings with and without

CP6.
INTERMITTENT HYPOXIA AGGRAVATES EARLY
PATHOGENESIS OF NON-ALCOHOLIC FATTY LIVER DISEASE
IN RATS
JF Pan,1 R Guo,2 EC Liong,2 GL Tipoe,2 ML Fung1
Departments of 1Physiology and 2Anatomy; Li Ka Shing Faculty of Medicine,
The University of Hong Kong, Hong Kong
Background/Aims: Chronic intermittent hypoxia (CIH) is associated with
recurrent episodes of oxygen desaturation and reoxygenation in obstructive
sleep apnea (OSA) patients. The prevalence of OSA is high in patients with
non-alcoholic fatty liver disease (NAFLD). The mechanistic effect of CIH
on the early pathogenesis of NAFLD remains elusive. Here we tested the
hypothesis that IH aggravates oxidative stress and inflammation induced by
high fat diet at an initial stage of pathogenesis of NAFLD in the rat liver.
Materials and Methods: Female Adult Sprague-Dawley rats were fed with
a diet comprising of high fat (30% fish oil) or normal diet for 4 weeks with
air (normoxic control) or CIH treatment (8 hours/day) which mimics
obstructive sleep apnea condition during the last 2 weeks. Liver injury was
detected by serum ALT and AST assay. Liver histology was evaluated by
H&E staining. Lipid peroxidation was examined by malondialdehyde (MDA)
assay and the expressions of pro-inflammatory cytokines (IL-1β, TNF-α,
IL-6) were determined by real-time PCR and ELISA.
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Results: Results showed that high fat diet (HFD) or CIH treatment increased
liver injury with significant elevated levels of ALT and AST and deteriorated
histological features of lipid accumulation in the liver. The effect of HFD
was more prominent in the group co-treated with hypoxia. In addition, levels
of MDA and the expressions of IL-1β, TNF-α and IL-6 were significantly
increased in the HFD- or hypoxia-treated group and were substantially
elevated in the co-treated group.
Conclusion: Intermittent hypoxia exacerbates oxidative stress and
inflammation induced by high fat diet in the rat liver, suggesting a significant
effect of CIH on aggravating the early pathogenesis of NAFLD.
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CP7.
PREVENTION OF GLYCERYL TRINITRATE TOLERANCE
BY FLAVONOIDS
L Zhang, SWS Leung, RYK Man
Department of Pharmacology and Pharmacy, The University of Hong Kong,
Hong Kong
Glyceryl trinitrate (GTN) is one of the most widely used anti-ischemic.
However, the development of tolerance after continuous application for 24
to 72 hours limits its clinical utility. Tolerance appears to be associated with
the oxidative stress induced by GTN in blood vessels. Flavonoids are
important components in herbal medicine. They have antioxidative effect
and potentiate vascular relaxation. In this study, the potential of nine
flavonoids to prevent GTN tolerance were examined. Changes in isometric
tension in thoracic aorta of Sprague Dawley rats were studied using organ
chamber technique. Aortic rings were treated with GTN (30 µM) for one
hour to induce GTN tolerance. They were incubated with or without flavonoids
for 30 minutes before GTN treatment. Afterwards, rings were contracted
with phenylephrine (1 µM) and relaxed with GTN (0.1 nM to 30 µM). GTNinduced relaxation was reduced by prior incubation with GTN; this reduction
was prevented by apigenin (10 µM), which did not affect the relaxations in
the control group (without prior treatment with GTN). On the other hand,
luteolin (10 µM) potentiated relaxations to GTN in both the control and GTNpre-treated groups. Therefore, apigenin may have the potential to prevent
the development of GTN tolerance.

CP8.
CHRONIC INTERMITTENT HYPOXIA INDUCES
DEPRESSIVE-LIKE BEHAVIOR IN RATS
CS Lam, 1 YY Liu, 2 GL Tipoe, 3 ML Fung 1
Departments of 1Physiology and 3Anatomy, The University of Hong Kong,
Hong Kong; 2Institute of Neurosciences, The Fourth Military Medical
University, Xi'an, China

than the control. However, MAP-2 protein level was not significantly
different between hypoxic and normoxic groups. Furthermore, the number
of PKC and PKC substrate positive-labeled cells were significantly reduced
by the CIH treatment. In conclusion, CIH induces depressive-like behavior
mediated by synaptic degeneration and reduced monoamine downstream
signaling.

Obstructive sleep apnea (OSA) causes recurrent oxygen desaturation (chronic
intermittent hypoxia, CIH) and is associated with depression in patients.
However, the relationship between OSA and depression is unclear. Synaptic
degeneration, microtubule instability and monoamine deficiency are the
common pathological features exhibited in both patients and depression
animal models. We hypothesized that CIH induces depressive-like behavior
by triggering synaptic degeneration, microtubule instability, and reducing
monoamine downstream signaling deficits in the hippocampus. Adult male
SD rats were exposed to air (normoxic) control or CIH treatment (8 hours/
day) for 7 days. Hippocampus was harvested for the measurement of markers
for synaptic vesicle protein (Synapsin I), microtubule stabilizing protein
(MAP-2), and monoamine downstream signaling (protein kinase C (PKC),
PKC substrate) using Western blot and immunohistochemical staining.
Depressive-like behavior was assessed by forced swimming test and sucrose
preference test. Immobility time was significantly elevated in the CIH-treated
group when comparing to the normoxic control. In addition, sucrose solution
consumption was remarkably reduced in the hypoxic group. Protein expression
levels of synapsin I and synaptophysin were much less in CIH-treated group
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IL6.

ELECTRICAL REMODELING OF THE FAILING HEART
AND THE RISK OF SUDDEN CARDIAC DEATH

GLP-1-ELEVATING AGENTS BENEFIT ENDOTHELIAL
FUNCTION

GF Tomaselli
Johns Hopkins University, USA

Y Huang
Institute of Vascular Medicine and Li Ka Shing Institute of Health Sciences,
The Chinese University of Hong Kong, Hong Kong

Heart failure with dyssynchronous ventricular contraction is associated with
genetically driven regional electrical remodeling of of the ventricle which
includes down regulation of K currents, increase in late Na current and altered
Ca2+ handling as well as remodeled connexin43 with reduced conduction
velocity. Cardiac resynchronization therapy (CRT) has the capacity to in
part reverse cellular structural, electrical and metabolic remodeling of the
failing heart.

Dipeptidyl peptidase-4 inhibition by sitagliptin stimulates insulin secretion by
preventing glucagon like peptide-1 (GLP-1) degradation. However, the role of
GLP-1 in hypertension is little studied. Our recent results show that sitagliptin
improves endothelial function in hypertension through both GLP-1-dependent
and -independent pathways by restoring NO bioavailability, suggesting that
GLP-1 and related agents can be a therapeutic target in hypertension-related
vascular events. Further examination shows that uncoupling protein-2 (UCP2)
is the downstream target of sitagliptin and GLP-1 receptor agonist. Angiotensin
II evoked endothelium-dependent contractions (EDCs) in C57BL/6 and UCP2
knockout (UCP2KO) mouse arotae. Chronic sitagliptin administration
attenuated EDCs in SHR arteries and Ang II-infused C57BL/6 mouse aortae,
and eliminated ROS overproduction in SHR arteries, which were reversed by
GLP-1 receptor (GLP-1R) antagonist exendin 9-39, AMPKα inhibitor
compound C, and UCP2 inhibitor genipin. By contrast, sitagliptin did not
EDCs in Ang II-infused UCP2KO mice. Exendin-4 also improved endothelial
function of renal arteries from SHR and hypertensive patients. UCP2 may
serve as an important signal molecule in endothelial protection conferred by
GLP-1-related agents. UCP2 could be a useful target in treating hypertensionrelated vascular events. (Supported by Hong Kong CRF grant)

IL7.

IL8.

RECENT ADVANCE IN CLINICAL MANAGEMENT OF
ACUTE CORONARY SYNDROME AND LIPID DISORDERS

RECENT ADVANCE IN IMAGING

MPH Chan
The University of Hong Kong, Hong Kong
Coronary artery disease remains one of the most important causes of
morbidities and mortalities despite improvements in coronary risk factor
management. The use of biomarkers and various non-invasive imaging
techniques help to risk-stratify patients who present with acute chest pain.
Randomized studies on anti-platelet and anti-thrombotic therapies further
refine our management of acute coronary syndromes. Lastly, the recently
published guideline on cholesterol management also made a great impact
on our daily practice. All these advances help to improve our clinical
management of acute coronary syndrome and lipid disorders.
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KY Yiu
The University of Hong Kong, Hong Kong
Speckle-tracking echocardiography has recently emerged as a quantitative
ultrasound technique for accurately evaluating myocardial function by
analyzing the motion of speckles identified on routine 2-dimensional
sonograms. It provides non-Doppler, angle-independent, and objective
quantification of myocardial deformation and left ventricular systolic and
diastolic dynamics. By tracking the displacement of the speckles during the
cardiac cycle,strain and the strain rate can be rapidly measured offline after
adequate image acquisition. Data regarding the feasibility, accuracy, and
clinical applications of speckle-tracking echocardiography are rapidly
accumulating. The talk will therefore focus of the use of this technique in
application for clinical research.
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P01.
FLUOXETINE-INDUCED CARDIAC DEPRESSION IS
ASSOCIATED WITH THE TOTAL MAGNESIUM EFFLUX IN
RATS
MY Lee
Department of Occupational Therapy, College of Health Science, Honam
University, Gwangju 506-714, Republic of Korea
Introduction: Fluoxetine was chosen as a prototypic serotoninselective
reuptake inhibitor (SSRI) without anticholinergic effects, while pemoline is
a stimulant that appears to act as an indirect dopamine agonist. Although
fluoxetine has been used in the field of anesthetic medicine, the cardiovascular
effects of fluoxetine is still controversial. This study investigated the relation
of magnesium (Mg) for fluoxetine-induced cardiac depression in rat.
Materials and Methods: The left ventricular development pressure (LVDP)
accompanied with the total magnesium efflux ([Mg]e) were measured
simultaneously in perfused hearts. The isolated heart was retrograde-perfused
with an oxygenated modified Krebs–Henseleit buffer. We attempted to
determine the values of total Mg, using atomic absorption spectrophotometer.
(Analab 9200)
Results:. Fluoxetine produced reversible decreases in the LVDP by increases
in the [Mg]e. The effect of fluoxetine was completely blocked by the
pretreatment of nifedipine, verapamil, imipramine or lidocaine and
accompanied with the total magnesium efflux ([Mg]e) were blocked too.
Conclusions: These results suggest that fluoxetine-induced cardiac depression
can be partly responsible to the increase in [Mg]e, but this reactions are
inhibited calcium and sodium ion channel blockers.

P02.
IMPAIRED COLD TOLERANCE IN EP4 KNOCKOUT MICE
IS NOT DUE TO COMPROMISED RECRUITMENT OF UCP1
F Ying,1 Y Cai,1 EHC Tang1,2
Department of Pharmacology and Pharmacy; 2Department of Physiology,
Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong

1

Objective: Uncoupling protein 1 (UCP1) is the key component of betaadrenergically controlled non-shivering thermogenesis in brown adipose tissue
(BAT). Certain white adipose tissue (WAT), upon exposition to cold, can
undergo a process knowing as browning where it takes on characteristics of
BAT, notably induction of UCP1 and the presence of multilocular lipid
droplets and multiple mitochondria. Our preliminary data indicated that mice
deficient in EP4 (one subtype of PGE2 receptor) are cold-intolerant, suggesting
that EP4 influence thermogenesis capacity. The aim of this project was to
investigate whether or not the impaired thermogenesis in EP4 knockout mice
is due to reduced recruitment of UCP1 in fat.
Methods: Male EP4 wild-type and knockout mice (12-15 weeks old)
were treated with CL316243 (a highly selective beta 3-adrenergic agonist,
1 mg/kg/day i.p) or saline for 10 days. Expression of UCP1, as well as other
thermogenesis-related genes in subcutaneous white adipose tissues (sWAT),
epididymal white adipose tissue (eWAT) and BAT of experimental mice
were compared. In addition, isolated fat from the experimental mice were
stained with hematoxylin and eosin and their morphology were compared.
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Results: After chronic CL316243 treatment, eWAT of EP4 knockout were
morphologically indistinguishable from that of wild-type mice. However,
sWAT and BAT of EP4 knockout have smaller multilocular lipid droplets
than wild-type mice. The expression of UCP1 and other thermogenesis-related
genes (including epithelial V like antigen 1, type II thyroxine deiodinase,
cell death inducing DFFA like effector A) in eWAT, sWAT and BAT did
not differ between EP4 knockout and wild-type mice. Interestingly, after
CL316243 treatment, there is a substantial increase in UCP3 mRNA in sWAT
of EP4 knockout as compared to wild-type mice. An enhanced level of UCP3
was also observed in BAT of EP4 knockout as compared to wild-type mice
under saline treatment.
Conclusions: Impaired cold tolerance in EP4 knockout mice is not due to
compromised recruitment of UCP1 in WAT and BAT. The enhanced level
of UCP3 in sWAT (after CL316243 treatment) and BAT (under basal
conditions) in EP4 knockout mice may possibly serve as a compensatory
mechanism to counteract the impaired thermogenesis observed in these mice.
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ROLE OF EXTRACELLULAR SIGNAL-REGULATED
KINASE IN THE REGULATION OF ENDOTHELIUMDEPENDENT RELAXATIONS IN PORCINE CORONARY
ARTERIES
TL Chiu, SWS Leung
Department of Pharmacology and Pharmacy, The University of Hong Kong,
Hong Kong
Objectives: Previous studies demonstrate that extracellular signal-regulated
kinase (ERK) contributes to vascular contraction. The present study examined
whether or not ERK modulated the different signaling pathways involved in
endothelium-dependent relaxation.
Methods: Isolated porcine coronary arteries, with and without endothelium,
were incubated in organ chamber for the measurement of isometric tension.
They were contracted with U46619 (thromboxane A 2 analogue, 30 to
100 nM) followed by cumulative additions of different relaxing agents, in
the presence or absence of the ERK inhibitor, U0126.
Results: In the presence of indomethacin (cyclooxygenase inhibitor; 10 µM),
the endothelium-dependent relaxing agent bradykinin (0.1 nM to 1 µM)
induced full relaxation, in a concentration-dependent manner, in arteries,
with endothelium, contracted with U46619. With addition of indomethacin
plus L-NAME [nitric oxide (NO) synthase inhibitor; 100 µM), bradykinininduced relaxation cannot be mediated via cyclooxygenase and NO pathways.
In this condition, U0126 (10 µM) enhanced relaxation thus suggesting that
ERK activation leads to inhibition of endothelium-dependent
hyperpolarization (EDH) type-mediated relaxations. When EDH pathway

was inhibited with TRAM-34 [intermediate conductance calcium-activated
potassium channel (IKCa) blocker; 1 µM] and UCL1684 [small conductance
calcium-activated potassium channel (SKCa) blocker; 1 µM], bradykinininduced relaxations in the presence of indomethacin were also potentiated
by U0126, thus suggesting a possible inhibitory action of ERK on the NO
pathway. On the other hand, U0126 did not significantly affect relaxations to
SKA-31 (IK Ca and SK Ca activator; 0.1 nM to 10 µM) in arteries with
endothelium. As such, the inhibitory action of ERK on EDH type-mediated
relaxation appears to be upstream of IKCa and SKCa activation. In arteries
without endothelium, relaxations to Deta NONOate (nitric oxide donor;
0.1 nM to 10 µM) and forskolin (adenylyl cyclase activator, 0.1 nM to
10 µM) were not affected by U0126.
Conclusions: Our data suggest that ERK inhibits the generation of NO and
EDH in the endothelium without affecting the signaling cascades downstream
of these relaxing signals in the smooth muscle. Moreover, it does not play a
role in the signaling cascade downstream of adenylyl cyclase activation in
the smooth muscle.

P04.
PROTEOMIC STUDY REVEALS CHANGES OF ACUTE PHASE
PROTEINS IN THE PLASMA OF PATIENTS WITH
CONGENITAL HEART DISEASE
X Zhang,1 K Wang,2 Q Yang,1,3 J Wang,1 C Xuan,1 GW He1,4
1
TEDA International Cardiovascular Hospital, Tianjin & The Affiliated
Hospital of Hangzhou Normal University& Zhejiang University, Hangzhou,
China; 2Department of Cardiovascular Surgery, Tianjin First Center Hospital,
Tianjin, China; 3Department of Medicine & Therapeutics, The Chinese
University of Hong Kong, Hong Kong; 4Department of Surgery, Oregon
Health and Science University, Portland, Oregon, U.S.A.
Objective: Ventricular septal defect (VSD), the most common congenital
heart disease, has intracardiac left-to-right shunt and increased pulmonary
flow that may affect the acute phase response. We examined the hypothesis
that plasma proteins of the VSD patients may be altered and related to the
pathogenesis of the disease.
Methods: In the plasma of VSD patients (n=55) and normal controls (n=55),
two-dimensional electrophoresis and mass spectrometry were used to detect
the differential protein profile and candidate proteins referred to acute phase
response were further confirmed by enzyme-linked immunosorbent assay in
new samples.
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Results: A total of 322 protein spots were detected among which 3 acute
phase proteins haptoglobin, serum amyloid P-component (SAP), and
orosomucoid 2 were differentially expressed. The level of haptoglobin
(0.4±0.04 vs. 0.6±0.07 mg/ml; p=0.016) and SAP (3.8±0.2 vs. 6.3±
0.8 ng/ml; p=0.003) in VSD patients were significantly lower than that
in normal controls. The level of orosomucoid 2 in VSD patients (3.1±
0.1 mg/ml) was significantly higher than that in normal controls (2.3±
0.1 mg/ml; p<0.000).
Conclusions: We have found that the plasma concentration of three acute
phase proteins, haptoglobin, SAP, and orosomucoid 2 are altered that
may reflect inflammation, be associated with decreased innate immune
system function, and predispose the VSD patients to vulnerability to
infections and pulmonary disease. These three proteins in plasma may
also be developed as biomarkers for the function of innate immune system
in patients with congenital heart disease.
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